2. PROTAC Cell Cycle/DNA Damage
  3. Molecular Glues CDK
  4. CDK2 degrader 6

CDK2 degrader 6 is an orally active and potent CDK2 molecular glue degrader with a DC50 of 46.5 nM. CDK2 degrader 6 binds to cereblon and CDK2 to induce ubiquitination and subsequent proteasomal degradation of CDK2. CDK2 degrader 6 modulates cell cycle in breast cancer cells. CDK2 degrader 6 reduces proliferation of breast cancer cells. CDK2 degrader 6 exhibits in vivo antitumor activity in gastric cancer mouse models. CDK2 degrader 6 can be used for the research of breast cancer, gastric cancer.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CDK2 degrader 6

CDK2 degrader 6 Chemische Struktur

CAS. Nr. : 3036606-92-2

Größe Preis Verfügbarkeit Menge
1 mg Auf Lager
5 mg Auf Lager
10 mg Auf Lager
50 mg   Angebot einholen  
100 mg   Angebot einholen  

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

This product is a controlled substance and not for sale in your territory.

Kundenbewertung

Based on 1 Customer Validation

Other Forms of CDK2 degrader 6:

CDK2 degrader 6 Related Antibodies

Top Publications Citing Use of Products

Alle CDK Isoform-spezifische Produkte anzeigen:

Alle Isoformen anzeigen
CDK1 CDK2 CDK3 CDK4 CDK5 CDK6 CDK7 CDK8 CDK9 CDK11 CDK12 CDK13 CDK14 CDK16 CDK19 CDC CLK Pho85 CDK10 CDK15 CDK17 CDK18 CDK20 PITSLRE

  • Biologische Aktivität

  • Reinheit & Dokumentation

  • Verweise

  • Kundenbewertung

Beschreibung

CDK2 degrader 6 is an orally active and potent CDK2 molecular glue degrader with a DC50 of 46.5 nM. CDK2 degrader 6 binds to cereblon and CDK2 to induce ubiquitination and subsequent proteasomal degradation of CDK2. CDK2 degrader 6 modulates cell cycle in breast cancer cells. CDK2 degrader 6 reduces proliferation of breast cancer cells. CDK2 degrader 6 exhibits in vivo antitumor activity in gastric cancer mouse models. CDK2 degrader 6 can be used for the research of breast cancer, gastric cancer[1].

IC50 & Target[1]

CDK2

46.5 nM (DC50)

In Vitro

CDK2 degrader 6 (compound 6) (24 h) potently induces degradation of CDK2 in CDK2 HiBiT-tagged HEK293 cells, with a 62.0% maximal reduction in CDK2 protein levels and a DC50 of 46.5 nM after 24 hours of treatment[1].
CDK2 degrader 6 (24 h) shows minimal activity in degrading GSPT1 in GSPT1 HiBiT-tagged HEK293 cells, with only a 9.9% maximal reduction in GSPT1 protein levels after 24 hours of treatment[1].
CDK2 degrader 6 (0.316-1000 nM; 7 days) potently inhibits proliferation of MDA-MB-157 breast cancer cells, with a 90% maximal reduction in cell proliferation and an EC50 of 10 nM after 7 days of treatment[1].
CDK2 degrader 6 (152 nM-1000 nM; 24 h) potently induces degradation of CDK2 protein in MDA-MB-157 breast cancer cells, with an 84% maximal reduction in CDK2 levels and a DC50 of 4 nM after 24 hours of treatment[1].
CDK2 degrader 6 (10-1000 nM; 24 h) disrupts the cell cycle of MDA-MB-157 breast cancer cells, causing dose-dependent G1 phase arrest and reduction in S phase cells after 24 hours of treatment at concentrations from 10 nM to 1000 nM[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

CDK2 degrader 6 Related Antibodies

Cell Proliferation Assay[1]

Cell Line: MDA-MB-157 breast cancer cells
Concentration: 0.316 nM, 1 nM, 3.16 nM, 10 nM, 31.6 nM, 100 nM, 316 nM, 1000 nM
Incubation Time: 7 days
Result: Reduced cell proliferation by 90% relative to DMSO controls, with an EC50 of 10 nM.

Western Blot Analysis[1]

Cell Line: MDA-MB-157 breast cancer cells
Concentration: 0.1 nM, 1 nM, 10 nM, 100 nM, 1000 nM
Incubation Time: 24 h
Result: Induced a maximal 84% reduction in CDK2 protein levels, with a DC50 of 4 nM.

Cell Cycle Analysis[1]

Cell Line: MDA-MB-157 breast cancer cells
Concentration: 10 nM, 100 nM, 1000 nM
Incubation Time: 24 h
Result: Caused a dose-dependent accumulation of cells in the G1 phase (56.3% in DMSO controls vs 65.4% at 1000 nM) and a reduction in cells in the S phase (35.8% in DMSO controls vs 3.1% at 1000 nM).
In Vivo

CDK2 degrader 6 (compound 6) (30-100 mg/kg; p.o.; twice daily; 21 days) produces significant antitumor activity in MKN1 gastric cancer xenografts, with 45% and 47% TGI respectively[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Mice injected with MKN1[1]
Dosage: 30 mg/kg; 100 mg/kg
Administration: p.o.; twice daily; 21 days
Result: Achieved 45% tumor growth inhibition (TGI) on day 21, with a statistically significant difference compared to vehicle.
Achieved 47% tumor growth inhibition (TGI) on day 21, with a statistically significant difference compared to vehicle.
Molekulargewicht

511.44

Formel

C23H22F5N5O3
CAS. Nr.
Appearance

Solid

Color

Off-white to light yellow

SMILES

O=C(C(CC1)C2=C(F)C=C(N3C[C@H](NC4=NN=C(C56CC(C6)(C(F)(F)F)C5)O4)[C@H]3C)C=C2F)NC1=O
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

-20°C, stored under nitrogen, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture)

Lösungsmittel & Löslichkeit
In Vitro: 

DMSO : 15 mg/mL (29.33 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 1.9553 mL 9.7763 mL 19.5526 mL
5 mM 0.3911 mL 1.9553 mL 3.9105 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molaritätsrechner

  • Verdünnungsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration: mg/mL
Reinheit & Dokumentation
Verweise

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.9553 mL 9.7763 mL 19.5526 mL 48.8816 mL
5 mM 0.3911 mL 1.9553 mL 3.9105 mL 9.7763 mL
10 mM 0.1955 mL 0.9776 mL 1.9553 mL 4.8882 mL
15 mM 0.1304 mL 0.6518 mL 1.3035 mL 3.2588 mL
20 mM 0.0978 mL 0.4888 mL 0.9776 mL 2.4441 mL
25 mM 0.0782 mL 0.3911 mL 0.7821 mL 1.9553 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

CDK2 degrader 6 Related Classifications

Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

CDK2 degrader 63036606-92-2Molecular GluesCDKCyclin dependent kinaseMDA-MB-157 breast cancer cellsGSPT1CDK2MKN1 gastric cancer xenograftsHEK293 cellsgastric cancer CDX mouse modelscereblonproteasomal degradationbreast cancer cellscell cycleInhibitorinhibitorinhibit

Ihre kürzlich angesehenen Produkte:

Online-Anfrage

Your information is safe with us. * Required Fields.

Produktname

  

Requested Quantity *

Name des Antragstellers *

 

Anrede

E-Mail-Addresse *

 

Telefonnummer *

Department

 

Name der Organisation *

City

Bundesland

Country or Region *

      

Bemerkungen

Massenanfrage

Inquiry Information

Produktname:
CDK2 degrader 6
Art. -Nr.:
HY-176444
Menge:
MCE Japan Authorized Agent:

Kundenbewertung

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Produktname

  

Lot #

Name des Antragstellers *

 

E-Mail-Addresse *

Telefonnummer

 

Department *

Name der Organisation *

 

Country or Region *

Bemerkungen

SAFETY DATA SHEET (SDS)

English - EN (252 KB) Français - FR (252 KB) Deutsch - DE (252 KB) Norwegian - NO (252 KB) Español - ES (252 KB) Swedish - SV (252 KB) Italian - IT (252 KB) Korean - KR (252 KB) Portuguese - PT (252 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.